Trend in Hospital Lengths of Stay and Readmissions
Overview
Medical and surgical innovations have allowed to shorter length of hospital stay (LOS). We assume that hospitals with uncontrolled reduction in LOS may expose patients to unsafe care. At the institutional level, a dynamic analysis of LOS evolution over time could clarify the existence of a link with the risk of readmission.
Full Title of Study: “Association Between Trend in Length of Stay and Risk of Readmission at Hospital After Surgery”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: March 2018
Interventions
- Other: Hospital stay
- Collection of hospital lengths of stay and readmissions
Arms, Groups and Cohorts
- Colorectal surgery
- Patient who underwent elective colorectal surgery
- Hip fracture
- Patient who underwent urgent surgical procedure for hip fracture
Clinical Trial Outcome Measures
Primary Measures
- Unplanned hospital readmission with death, intensive care, or reoperation
- Time Frame: 30 days
- Number of unplanned hospital readmission with death, intensive care, or reoperation within 30 days of surgical procedure
Secondary Measures
- Unplanned hospital readmission with death, intensive care, or reoperation
- Time Frame: 3 months
- Number of unplanned hospital readmission with death, intensive care, or reoperation within 3 months of surgical procedure
- Unplanned hospital readmission with death, intensive care, or reoperation
- Time Frame: 6 months
- Number of unplanned hospital readmission with death, intensive care, or reoperation within 6 months of surgical procedure
Participating in This Clinical Trial
Inclusion Criteria
- All patients who underwent elective colorectal surgery or urgent surgical procedure for hip fracture in French public and private hospitals from January 2014 to December 2016 Exclusion Criteria:
- Age < 18 years old – Death during the index stay
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Hospices Civils de Lyon
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Antoine DUCLOS, MD, PhD, Principal Investigator, Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon
- Overall Contact(s)
- Antoine DUCLOS, MD, PhD, 04 72 11 51 66, antoine.duclos@chu-lyon.fr
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.